Larvol Delta - New-Registrational-Trial-Upcoming-for-Efzotimod-After-Positive-FDA-Feedback

Stalaris (efzofitimod) - aTyr Pharma, Kyorin

https://sarcoidosisnews.com/2022/03/11/efzofitimod-more-clinical-testing-fda-feedback/

Mar 11, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next